Low-value Care

Unnecessary stents can cost Medicare $800 million a year, new analysis estimates

Abstract: A report out today from the Lown Institute says unnecessary use of coronary stents could cost Medicare an estimated $800 million a year. Looking at more than 1,700 hospitals and outpatient centers, the think tank determined more than 1 in 5 procedures from 2019 through 2021 met criteria for overuse.

Date Published: October 31, 2023

Author(s): Elizabeth Cooney

Publication: STAT+ Morning Rounds

View This Resource

To eliminate medication overload, serious cultural, educational, and policy changes are needed. This action plan offers recommendations for policymakers, health care institutions, clinicians, and patients across five key categories to reduce harm from multiple medication use. Suggested Citation: Eliminating medication overload: A national action plan. Working Group on Medication Overload. Brookline, MA: The Lown Institute, 2020. DOI: https://doi.org/10.46241/LI.YLBW4885

Pharmaceutical marketing is a significant factor in the growing public health crisis of medication overload, which puts millions of older adults at risk of preventable harm and premature death. This issue brief provides recommendations to reduce pharmaceutical industry influence by limiting pharma sales rep visits to clinicians and direct-to-consumer advertising.

This issue brief provides recommendations for clinical practice guidelines and electronic health records that would give clinicians the information they need to appropriately prescribe and deprescribe.